Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.66 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.66 |
| ▸ | LMNA | P02545 | 5/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.66 |
| ▸ | NPC1 | O15118 | 5/20 | 0.65 |
| ▸ | RAB9A | P51151 | 4/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.57 |
| ▸ | HPGD | P15428 | 4/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.57 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.57 |
| ▸ | PGR | P06401 | 2/20 | 0.57 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.57 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.57 |
| ▸ | AR | P10275 | 1/20 | 0.57 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.57 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.57 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30433307 | 1.00 | MAPT (0.66) | MAPTKMT2ALMNAALDH1A1NPC1 | |
| SCHEMBL10491875 | 0.99 | MAPT (0.64) | MAPTKMT2ALMNAALDH1A1NPC1 | |
| SCHEMBL31202078 | 0.99 | MAPT (0.64) | MAPTKMT2ALMNAALDH1A1NPC1 | |
| SCHEMBL29967586 | 0.99 | MAPT (0.64) | MAPTKMT2ALMNAALDH1A1NPC1 | |
| SCHEMBL6054787 | 0.99 | MAPT (0.64) | MAPTKMT2ALMNAALDH1A1NPC1 | |
| SCHEMBL29466728 | 0.99 | MAPT (0.64) | MAPTKMT2ALMNAALDH1A1NPC1 | |
| SCHEMBL345162 | 0.99 | MAPT (0.64) | MAPTKMT2ALMNAALDH1A1NPC1 | |
| SCHEMBL10491558 | 0.99 | MAPT (0.64) | MAPTKMT2ALMNAALDH1A1NPC1 | |
| SCHEMBL9619909 | 0.93 | NPC1 (0.63) | MAPTKMT2ALMNAALDH1A1NPC1 | |
| Sulisobenzone SCHEMBL7561904 | 0.92 | MAPT (0.82) | MAPTKMT2ALMNAALDH1A1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 301 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10375952-B2 | Composition containing a cellulose derived capsule with a sunscreen | CoLabs International Corporation (US) | 2019-08-13 | — | — | US | claimed |
| US-9232785-B2 | Method for reducing sunburn damage in plants | BASF SE (DE) | 2016-01-12 | — | — | US | claimed |
| US-8748347-B2 | Method for combating harmful fungi | BASF SE (DE) | 2014-06-10 | — | — | US | claimed |
| US-20120083497-A1 | Method for Combating Harmful Fungi | BASF SE (DE) | 2012-04-05 | — | — | US | claimed |
| EP-2418944-A2 | METHOD FOR COMBATING HARMFUL FUNGI | BASF SE (DE) | 2012-02-22 | — | — | EP | claimed |
| EP-2413691-A2 | METHOD FOR REDUCING SUNBURN DAMAGE IN PLANTS | BASF SE (DE) | 2012-02-08 | — | — | EP | claimed |
| US-20120017503-A1 | METHOD FOR REDUCING SUNBURN DAMAGE IN PLANTS | BASF SE (DE) | 2012-01-26 | — | — | US | claimed |
| WO-2010115721-A2 | METHOD FOR REDUCING SUNBURN DAMAGE IN PLANTS | BASF SE (DE) | 2010-10-14 | — | — | WO | claimed |
| WO-2010115720-A2 | METHOD FOR COMBATING HARMFUL FUNGI | BASF SE (DE) | 2010-10-14 | — | — | WO | claimed |
| US-20050014951-A1 | Photoprotective and lightfastness-enhancing siloxanes | XEROX CORPORATION | 2005-01-20 | — | — | US | claimed |
| US-6803395-B2 | POLYSILOXANE HAVING THEREON A HYDROPHILIC MOIETY AND A LIGHTFASTNESS MOIETY | XEROX CORPORATION | 2004-10-12 | — | — | US | claimed |
| US-20030137570-A1 | Photoprotective and lightfastness-enhancing siloxanes | XEROX CORPORATION | 2003-07-24 | — | — | US | claimed |
| US-20030133886-A1 | Photoprotective and lightfastness-enhancing siloxanes | XEROX CORPORATION | 2003-07-17 | — | — | US | claimed |
| US-20030119940-A1 | Ink composition with improved lightfastness | XEROX CORPORATION | 2003-06-26 | — | — | US | claimed |
| US-6569511-B1 | Polysiloxane having a hydrophilic moiety and a lightfastness moiety; ink jet coating | XEROX CORPORATION | 2003-05-27 | — | — | US | claimed |
| US-6365139-B2 | Cosmetic stick | AVON PRODUCTS, INC. | 2002-04-02 | — | — | US | claimed |
| JP-62161753-A | — | — | None | — | — | JP | disclosed |
| WO-2026100525-A1 | BLACK RESIN PARTICLE DISPERSION AND AQUEOUS INK COMPOSITION FOR WRITING IMPLEMENTS CONTAINING SAME | 三菱鉛筆株式会社 | 2026-05-15 | — | — | WO | disclosed |
| US-4113487-A | LAYER OF PHOTO-SETTING AND EXPANDABLE RESIN EXPOSED TO PARTIALLY SCREENED LIGHT | TOPPAN PRINTING CO., LTD. (JP) | 1978-09-12 | — | — | US | disclosed |
| US-3933495-A | Producing planographic printing plate requiring no dampening water | FUJI PHOTO FILM CO., LTD. (JA) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10375952-B2 | Composition containing a cellulose derived capsule with a sunscreen | MSH6, TYR, CUTA | MAPT 108/4885KMT2A 3360/4885LMNA 3451/4885 |
| US-20050014951-A1 | Photoprotective and lightfastness-enhancing siloxanes | LRRFIP1, LRRC59, MMS19 | MAPT 3797/4885KMT2A 1571/4885LMNA 396/4885 |
| US-20120017503-A1 | METHOD FOR REDUCING SUNBURN DAMAGE IN PLANTS | UNG, ERCC5, ERCC4 | MAPT 1222/4885KMT2A 3578/4885LMNA 465/4885 |
| US-20030133886-A1 | Photoprotective and lightfastness-enhancing siloxanes | ITGA1, ITGB1, ITGB8 | MAPT 3866/4885KMT2A 1558/4885LMNA 296/4885 |
| US-20120083497-A1 | Method for Combating Harmful Fungi | BROX, CRY1, GUSB | MAPT 624/4885KMT2A 2802/4885LMNA 2775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.